市場調查報告書

癌症對症療法產品市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Cancer Supportive Care Products Market, By Drug Class, By Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968707
出版日期 內容資訊 英文 175 Pages
商品交期: 2-3個工作天內
價格
癌症對症療法產品市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年 Cancer Supportive Care Products Market, By Drug Class, By Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月15日內容資訊: 英文 175 Pages
簡介

癌症對症療法是為患有不同類型癌症的患者提供的護理。癌症的高發率以及與生物製藥業資本增加相關的研發的增加預計將在預測期內推動市場增長。

本報告提供全球癌症對症療法產品市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場範圍

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的焦點
  • 產品銷售
  • PEST分析
  • 技術的進步
  • 法規方案
  • M&A

第4章 全球癌症對症療法產品市場:各藥物分類

  • 簡介
  • 非類固醇消炎劑 (NSAIDs)
  • 抗感染疾病藥
  • 制吐藥
  • 單株抗體
  • 促血紅細胞生長素刺激劑 (ESA)
  • 類鴉片物質止痛藥
  • 雙磷酸鹽 (BP)
  • 顆粒細胞增生因子 (G-CSF)

第5章 全球癌症對症療法產品市場:各適應症

  • 簡介
  • 肺癌症
  • 乳癌
  • 前列腺癌症
  • 肝臟癌症
  • 膀胱癌
  • 白血病
  • 卵巢癌症
  • 黑色素瘤
  • 其他

第6章 全球癌症對症療法產品市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第7章 全球癌症對症療法產品市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 企業簡介
    • Amgen Inc.
    • Johnson & Johnson Private Ltd.
    • Merck
    • Novartis AG
    • Baxter International
    • Hoffmann-La Roche Ltd.
    • Fagron
    • Teva Pharmaceutical Industries Ltd.
    • G1 Therapeutics Inc.
    • APR Applied Pharma Research SA
    • Acacia Pharma
    • FUJIFILM Medical Systems USA
    • EMD Serono
    • Kyowa Hakko Kirin Co., Ltd.

第9章 章節

目錄

Title:
Cancer Supportive Care Products Market, By Drug Class (Nonsteroidal Anti- Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

  • Cancer supportive care is associated with care given to the patients suffering from various types of cancer. Supportive care is intended for relieving suffering of the patients and improving their quality of life. The main aim of supportive care is to improve the quality of life of the patient. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. High prevalence of cancer, increasing research and development along with increasing investment in biopharmaceutical industry are anticipated to drive the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Cancer Supportive Care Products market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Cancer Supportive Care Products market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Amgen Inc., Johnson & Johnson Private Ltd., Merck, Novartis AG, Baxter International, Hoffmann-La Roche Ltd., Fagron, Teva Pharmaceutical Industries Ltd., G1 Therapeutics Inc., APR Applied Pharma Research s.a., Acacia Pharma, EMD Serono, and Kyowa Hakko Kirin Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Cancer Supportive Care Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cancer Supportive Care Products market

Detailed Segmentation:

  • Global Cancer Supportive Care Products Market, By Drug Class:
    • Nonsteroidal Anti- Inflammatory Drugs
    • Anti-Infective
    • Anti-Emetics
    • Monoclonal Antibodies
    • Erythropoietin Stimulating Agents
    • Opioid Analgesics
    • Bisphosphonates
    • Granulocyte Colony Stimulating Factor
  • Global Cancer Supportive Care Products Market, By Indication:
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Leukemia
    • Ovary Cancer
    • Melanoma Cancer
    • Others
  • Global Cancer Supportive Care Products Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Compounding Pharmacies
  • Global Cancer Supportive Care Products Market, By Region:
  • North America
    • By Drug Class:
    • Nonsteroidal Anti- Inflammatory Drugs
    • Anti-Infective
    • Anti-Emetics
    • Monoclonal Antibodies
    • Erythropoietin Stimulating Agents
    • Opioid Analgesics
    • Bisphosphonates
    • Granulocyte Colony Stimulating Factor
    • By Indication
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Leukemia
    • Ovary Cancer
    • Melanoma Cancer
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Compounding Pharmacies
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Drug Class:
    • Nonsteroidal Anti- Inflammatory Drugs
    • Anti-Infective
    • Anti-Emetics
    • Monoclonal Antibodies
    • Erythropoietin Stimulating Agents
    • Opioid Analgesics
    • Bisphosphonates
    • Granulocyte Colony Stimulating Factor
    • By Indication
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Leukemia
    • Ovary Cancer
    • Melanoma Cancer
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Compounding Pharmacies
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Drug Class:
    • Nonsteroidal Anti- Inflammatory Drugs
    • Anti-Infective
    • Anti-Emetics
    • Monoclonal Antibodies
    • Erythropoietin Stimulating Agents
    • Opioid Analgesics
    • Bisphosphonates
    • Granulocyte Colony Stimulating Factor
    • By Indication
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Leukemia
    • Ovary Cancer
    • Melanoma Cancer
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Compounding Pharmacies
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Drug Class:
    • Nonsteroidal Anti- Inflammatory Drugs
    • Anti-Infective
    • Anti-Emetics
    • Monoclonal Antibodies
    • Erythropoietin Stimulating Agents
    • Opioid Analgesics
    • Bisphosphonates
    • Granulocyte Colony Stimulating Factor
    • By Indication
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Leukemia
    • Ovary Cancer
    • Melanoma Cancer
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Compounding Pharmacies
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Drug Class:
    • Nonsteroidal Anti- Inflammatory Drugs
    • Anti-Infective
    • Anti-Emetics
    • Monoclonal Antibodies
    • Erythropoietin Stimulating Agents
    • Opioid Analgesics
    • Bisphosphonates
    • Granulocyte Colony Stimulating Factor
    • By Indication
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Leukemia
    • Ovary Cancer
    • Melanoma Cancer
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Compounding Pharmacies
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Drug Class:
    • Nonsteroidal Anti- Inflammatory Drugs
    • Anti-Infective
    • Anti-Emetics
    • Monoclonal Antibodies
    • Erythropoietin Stimulating Agents
    • Opioid Analgesics
    • Bisphosphonates
    • Granulocyte Colony Stimulating Factor
    • By Indication
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Liver Cancer
    • Bladder Cancer
    • Leukemia
    • Ovary Cancer
    • Melanoma Cancer
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Compounding Pharmacies
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Amgen Inc.*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Johnson & Johnson Private Ltd.
  • Merck
  • Novartis AG
  • Baxter International
  • Hoffmann-La Roche Ltd.
  • Fagron
  • Teva Pharmaceutical Industries Ltd.
  • G1 Therapeutics Inc.
  • APR Applied Pharma Research S.A.
  • Acacia Pharma
  • EMD Serono
  • Kyowa Hakko Kirin Co., Ltd.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Indication
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Cancer Supportive Care Products Market, By Drug Class, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Nonsteroidal Anti- Inflammatory Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Anti-Infective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Anti-Emetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Erythropoietin Stimulating Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Opioid Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Bisphosphonates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Granulocyte Colony Stimulating Factor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Cancer Supportive Care Products Market, By Indication, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Liver Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Bladder Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Leukemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ovary Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Melanoma Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Cancer Supportive Care Products Market, By Distribution CHannel, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Cancer Supportive Care Products Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Indication, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Company Profiles
    • Amgen Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson Private Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Baxter International
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hoffmann-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fagron
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • G1 Therapeutics Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • APR Applied Pharma Research S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Acacia Pharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • FUJIFILM Medical Systems U.S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • EMD Serono
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Kyowa Hakko Kirin Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact